← FDA DRUG APPROVALS

FDA ANDA · ANDA071803

DESIPRAMINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA071803
TYPE
ANDA
ORIGINAL APPROVAL
1997-05-29
LATEST ACTION
2000-07-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 75MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 25MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 150MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 50MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2000-07-07Manufacturing (CMC) · Supplement 1AP
1997-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →